Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OctaHeal Colostrum
- Development stage
- Unknown
- Lead developer
- Faran Shimi
- Administration
- Oral
01
Overview
OctaHeal Colostrum is a nutraceutical supplement developed and marketed by Faran Shimi. It is composed of bovine colostrum, the first milk produced by cows after giving birth, which is naturally rich in bioactive molecules. Key components include immunoglobulins (primarily IgG), which provide passive immunity; lactoferrin, an antimicrobial protein; and growth factors such as IGF-1 and TGF-β, which support tissue repair and gut health. The product is used to enhance immune system response, maintain gastrointestinal barrier integrity, and support overall health. It is available as an over-the-counter product in the Iranian market.
- Brand names
- OctaHeal Colostrum
- Other names
- Colostrum
Beyond the preview
Go deeper on OctaHeal Colostrum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OctaHeal Colostrum.